The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial
Open accessAbstract
Importance: Slowing myopia progression could decrease the risk of sight-threatening complications. Objective: To determine whether soft multifocal contact lenses slow myopia progression in children, and whether high add power (+2.50 D) slows myopia progression more than medium (+1.50 D) add power lenses. Design, Setting, and Participants: A double-masked randomized clinical trial that took place at 2 optometry schools located in Columbus, Ohio, and Houston, Texas. A total of 294 consecutive eligible children aged 7 to 11 years with -0.75 D to -5.00 D of spherical component myopia and less than 1.00 D astigmatism were enrolled between September 22, 2014, and June 20, 2016. Follow-up was completed June 24, 2019. Interventions: Participants were randomly assigned to wear high add power (n = 98), medium add power (n = 98), or single-vision (n = 98) contact lenses. Main Outcomes and Measures: The primary outcome was the 3-year change in cycloplegic spherical equivalent autorefraction, as measured by the mean of 10 autorefraction readings. There were 11 secondary end points, 4 of which were analyzed for this study, including 3-year eye growth. Results: Among 294 randomized participants, 292 (99%) were included in the analyses (mean [SD] age, 10.3 [1.2] years; 177 [60.2%] were female; mean [SD] spherical equivalent refractive error, -2.39 [1.00] D). Adjusted 3-year myopia progression was -0.60 D for high add power, -0.89 D for medium add power, and -1.05 D for single-vision contact lenses. The difference in progression was 0.46 D (95% CI, 0.29-0.63) for high add power vs single vision, 0.30 D (95% CI, 0.13-0.47) for high add vs medium add power, and 0.16 D (95% CI, -0.01 to 0.33) for medium add power vs single vision. Of the 4 secondary end points, there were no statistically significant differences between the groups for 3 of the end points. Adjusted mean eye growth was 0.42 mm for high add power, 0.58 mm for medium add power, and 0.66 mm for single vision. The difference in eye growth was -0.23 mm (95% CI, -0.30 to -0.17) for high add power vs single vision, -0.16 mm (95% CI, -0.23 to -0.09) for high add vs medium add power, and -0.07 mm (95% CI, -0.14 to -0.01) for medium add power vs single vision. Conclusions and Relevance: Among children with myopia, treatment with high add power multifocal contact lenses significantly reduced the rate of myopia progression over 3 years compared with medium add power multifocal and single-vision contact lenses. However, further research is needed to understand the clinical importance of the observed differences. Trial Registration: ClinicalTrials.gov Identifier: NCT02255474.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Thibos, L. N., WHEELER, W., & Horner, D. G. (1997) · Optometry and Vision Science · doi:10.1002/j.1538-9235.1997.tb04707.x · Cited by 1,238
Retardation of Myopia in Orthokeratology (ROMIO) Study: A 2-Year Randomized Clinical Trial
Cho, P., & Cheung, S.-W. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10565 · Cited by 818
Parental History of Myopia, Sports and Outdoor Activities, and Future Myopia
Jones, L. A., Sinnott, L. T., Mutti, D. O., Mitchell, G. L., Moeschberger, M. L., & Zadnik, K. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1118 · Cited by 769
Self-citationLow-Concentration Atropine for Myopia Progression (LAMP) Study
Yam, J. C., Jiang, Y., Tang, S. M., Law, A. K. P., Chan, J. J., Wong, E., Ko, S. T., Young, A. L., Tham, C. C., Chen, L. J., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.029 · Cited by 724
Gwiazda, J., Hyman, L., Hussein, M., Everett, D., Norton, T. T., Kurtz, D., Leske, M. C., Manny, R., Marsh-Tootle, W., & Scheiman, M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0816 · Cited by 595
(2020) · Clinical ophthalmology · doi:10.2147/opth · Cited by 589
A 3‐year Randomized Clinical Trial of MiSight Lenses for Myopia Control
Chamberlain, P., Peixoto‐de‐Matos, S. C., Logan, N. S., Ngo, C., Jones, D., & Young, G. (2019) · Optometry and Vision Science · doi:10.1097/opx.0000000000001410 · Cited by 516
Cited by
Bao, J., Huang, Y., Li, X., Yang, A., Zhou, F., Wu, J., Wang, C., Li, Y., Lim, E. W., Spiegel, D. P., et al. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.0401 · Cited by 304
Metadata
- Authors
- Walline, J. J., Walker, M. K., Mutti, D. O., Jones-Jordan, L. A., Sinnott, L. T., Giannoni, A. G., Bickle, K. M., Schulle, K. L., Nixon, A., Pierce, G. E., Berntsen, D. A., & for the BLINK Study Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-08-11
- Volume
- 324
- Issue
- 6
- Pages
- 571
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3048606831
- Cited by
- 304
- References
- 27
- FWCI
- 23.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2020.10834
- The paper
- Walline, J. J., Walker, M. K., Mutti, D. O., Jones-Jordan, L. A., Sinnott, L. T., Giannoni, A. G., Bickle, K. M., Schulle, K. L., Nixon, A., Pierce, G. E., Berntsen, D. A., & for the BLINK Study Group. (2020). Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.10834
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.